Soltis Investment Advisors LLC Regeneron Pharmaceuticals, Inc. Transaction History

Soltis Investment Advisors LLC

  • $1.01 Billion
  • Q3 2024

A detailed history of Soltis Investment Advisors LLC transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Soltis Investment Advisors LLC holds 711 shares of REGN stock, worth $499,015. This represents 0.07% of its overall portfolio holdings.

Number of Shares
711
Previous 683 4.1%
Holding current value
$499,015
Previous $717,000 4.18%
% of portfolio
0.07%
Previous 0.08%

Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 18, 2024
BUY
$1024.09 - $1201.76 $28,674 - $33,649
28 Added 4.1%
711 $747,000
Q2 2024

Aug 12, 2024
BUY
$883.2 - $1071.19 $7,948 - $9,640
9 Added 1.34%
683 $717,000
Q1 2024

Apr 29, 2024
SELL
$902.69 - $993.35 $8,124 - $8,940
-9 Reduced 1.32%
674 $648,000
Q4 2023

Jan 26, 2024
SELL
$775.18 - $881.7 $32,557 - $37,031
-42 Reduced 5.79%
683 $599,000
Q3 2023

Nov 08, 2023
SELL
$692.45 - $844.37 $6,232 - $7,599
-9 Reduced 1.23%
725 $596,000
Q2 2023

Aug 08, 2023
SELL
$700.03 - $830.35 $5,600 - $6,642
-8 Reduced 1.08%
734 $527,000
Q1 2023

May 03, 2023
BUY
$680.49 - $826.97 $31,983 - $38,867
47 Added 6.76%
742 $609,000
Q4 2022

Feb 09, 2023
SELL
$705.89 - $766.39 $7,058 - $7,663
-10 Reduced 1.42%
695 $501,000
Q3 2022

Nov 14, 2022
BUY
$573.97 - $724.32 $36,160 - $45,632
63 Added 9.81%
705 $486,000
Q2 2022

Aug 11, 2022
BUY
$548.35 - $738.84 $6,031 - $8,127
11 Added 1.74%
642 $380,000
Q1 2022

May 06, 2022
BUY
$595.12 - $698.43 $26,780 - $31,429
45 Added 7.68%
631 $441,000
Q4 2021

Feb 09, 2022
SELL
$543.48 - $670.97 $1,086 - $1,341
-2 Reduced 0.34%
586 $370,000
Q3 2021

Nov 09, 2021
BUY
$574.03 - $680.96 $2,296 - $2,723
4 Added 0.68%
588 $356,000
Q2 2021

Aug 04, 2021
BUY
$472.8 - $558.54 $13,711 - $16,197
29 Added 5.23%
584 $326,000
Q1 2021

May 11, 2021
BUY
$446.73 - $548.2 $4,914 - $6,030
11 Added 2.02%
555 $263,000
Q4 2020

Feb 10, 2021
BUY
$478.3 - $607.98 $6,217 - $7,903
13 Added 2.45%
544 $263,000
Q3 2020

Oct 28, 2020
BUY
$544.75 - $658.21 $16,887 - $20,404
31 Added 6.2%
531 $297,000
Q1 2020

May 07, 2020
BUY
$336.18 - $494.43 $168,090 - $247,215
500 New
500 $244,000

Others Institutions Holding REGN

# of Institutions
1,534
Shares Held
83.6M
Call Options Held
1.22M
Put Options Held
1.51M
View Full List

About REGENERON PHARMACEUTICALS, INC.

REGN Quotes by TradingView
  • Ticker REGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 107,190,000
  • Market Cap $75.2B
  • Description
  • Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...
More about REGN
Track This Portfolio

Track Soltis Investment Advisors LLC Portfolio

Follow Soltis Investment Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Soltis Investment Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Soltis Investment Advisors LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email